The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

There is common ground. Most adults favor: Preventing chronic diseases (Republicans 86%, Democrats 91%) Protecting against ...

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...

A group of public health experts and scientists is mobilizing to counter vaccine misinformation from federal agencies, in an ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Today marks 100 days since President Donald Trump took office — a period for the health care world that’s been distinguished ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Continuity Biosciences, LLC has made a strategic investment in PinPrint, Inc., a pioneering company in high-resolution ...